Sk Biopharmaceuticals Co Ltd (326030) — Financial Flexibility Index
Sk Biopharmaceuticals Co Ltd (326030) has a Financial Flexibility Index of 0.31x as of December 2025. Free cash flow of ₩113.55 Billion (operating CF ₩87.00 Billion minus capex ₩26.55 Billion) represents 0% of total liabilities (₩372.04 Billion). Check Sk Biopharmaceuticals Co Ltd (326030) strategic asset index to assess the company's strategic physical and investment asset allocation.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Sk Biopharmaceuticals Co Ltd Financial Flexibility Index (2016–2025)
Historical Financial Flexibility Index trend for Sk Biopharmaceuticals Co Ltd across 10 annual periods. See Sk Biopharmaceuticals Co Ltd working capital to net assets to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for Sk Biopharmaceuticals Co Ltd (2016–2025)
Year-by-year free cash flow to debt coverage for Sk Biopharmaceuticals Co Ltd. For the full company profile including market capitalisation, see how much is Sk Biopharmaceuticals Co Ltd worth.
| Year | Flexibility Index | Free Cash Flow (KRW) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.55x | ₩205.84 Billion | ₩176.33 Billion | ₩372.04 Billion | ▲ +136.4% |
| 2024 | 0.23x | ₩108.32 Billion | ₩94.90 Billion | ₩462.83 Billion | ▲ +203.5% |
| 2023 | -0.23x | ₩-90.95 Billion | ₩-94.20 Billion | ₩402.22 Billion | ▲ +49.3% |
| 2022 | -0.45x | ₩-155.01 Billion | ₩-159.92 Billion | ₩347.68 Billion | ▼ -0.4% |
| 2021 | -0.44x | ₩-88.56 Billion | ₩-92.87 Billion | ₩199.46 Billion | ▲ +73.1% |
| 2020 | -1.65x | ₩-199.70 Billion | ₩-210.73 Billion | ₩121.17 Billion | ▼ -272.5% |
| 2019 | -0.44x | ₩-67.29 Billion | ₩-81.33 Billion | ₩152.10 Billion | ▲ +88.3% |
| 2018 | -3.79x | ₩-139.85 Billion | ₩-141.28 Billion | ₩36.91 Billion | ▼ -100.3% |
| 2017 | -1.89x | ₩-96.70 Billion | ₩-98.34 Billion | ₩51.12 Billion | ▼ -117.7% |
| 2016 | -0.87x | ₩-40.14 Billion | ₩-48.94 Billion | ₩46.21 Billion | — |